Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Lung cancer (Amsterdam, Netherlands)"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Tamura%2C+Tomohide%22&type=Person&filter%5B%5D=journalStr%3A%22Lung+cancer+%28Amsterdam%2C+Netherlands%29%22
/vufind/Search/Results?lookfor=%22Tamura%2C+Tomohide%22&type=Person&filter%5B%5D=journalStr%3A%22Lung+cancer+%28Amsterdam%2C+Netherlands%29%22
Search /vufind/Search2/Results?lookfor=%22Tamura%2C+Tomohide%22&type=Person&filter%5B%5D=journalStr%3A%22Lung+cancer+%28Amsterdam%2C+Netherlands%29%22
PubPharm (22)
1
Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2020
von
Nakagawa, K.
|
Hida, T.
|
Nokihara, H.
| +20
Wird geladen...
2
A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2019
von
Hida, T.
|
Velcheti, V.
|
Reckamp, K.
| +7
Wird geladen...
3
Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2019
von
Udagawa, H.
|
Akamatsu, H.
|
Tanaka, K.
| +13
Wird geladen...
4
Corrigendum to "Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer" [Lung Cancer 121 (July) (2018) Pages 37-40
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2019
von
Nishio, M.
|
Nakagawa, K.
|
Mitsudomi, T.
| +5
ErratumFor: Lung Cancer. 2018 Jul;121:37-40. - PMID 29858024
Wird geladen...
5
Corrigendum to "Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer : A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan" [Lung Cancer, 129 (March) (2019) 55-62
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2019
von
Watanabe, S.
|
Yoshioka, H.
|
Sakai, H.
| +19
ErratumFor: Lung Cancer. 2019 Mar;129:55-62. - PMID 30797492
Wird geladen...
6
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer : A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2019
von
Watanabe, S.
|
Yoshioka, H.
|
Sakai, H.
| +19
ErratumIn: Lung Cancer. 2019 Jun;132:157-158. - PMID 31014853
Wird geladen...
7
Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2018
von
Nishio, M.
|
Nakagawa, K.
|
Mitsudomi, T.
| +5
ErratumIn: Lung Cancer. 2019 Jun;132:160. - PMID 31029398
Wird geladen...
8
Randomized phase II trial of weekly dose-intensive chemotherapy or amrubicin plus cisplatin chemotherapy following induction chemoradiotherapy for limited-disease small cell lung cancer (JCOG1011)
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2017
von
Sekine, I.
|
Harada, H.
|
Yamamoto, N.
| +11
Wird geladen...
9
Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2017
von
Katakami, N.
|
Hida, T.
|
Nokihara, H.
| +9
Wird geladen...
10
Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2017
von
Kato, T.
|
Masuda, N.
|
Nakanishi, Y.
| +10
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Lung cancer (Amsterdam, Netherlands)
Medienart
22
Aufsätze
17
E-Artikel
17
E-Ressourcen
5
Gedruckte Aufsätze
Zeitschriftentitel
Lung cancer (Amsterdam, Netherlands)
Thema
20
Journal Article
10
Research Support, Non-U.S. Gov't
8
Antineoplastic Agents
8
EC 2.7.10.1
8
Multicenter Study
7
Clinical Trial, Phase II
6
Cisplatin
6
Q20Q21Q62J
5
ErbB Receptors
5
Non-small cell lung cancer
4
Antibodies, Monoclonal, Humanized
4
Clinical Trial, Phase I
4
Gefitinib
4
Quinazolines
4
Randomized Controlled Trial
4
Taxoids
3
15H5577CQD
3
Antibodies, Monoclonal
3
Docetaxel
3
Non-small-cell lung cancer
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2020-
15
2010-2019
6
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
22
Englisch
Haven't found what you're looking for?
Wird geladen...